Synaptic Ventures

Synaptic Ventures is a venture capital firm dedicated to investing in early-stage companies within the life sciences and healthcare sectors. The firm aims to empower innovators by providing strategic financial guidance and unlocking global investment opportunities. Their investment approach is centered on identifying and supporting companies that have the potential to make significant impacts in the healthcare industry.

The firm's investment strategy encompasses various stages, including Seed, Series A, and Series B funding, with investment sizes ranging from $1 million to $50 million. Synaptic Ventures has a global geographical focus, with investments in regions such as the United States, Singapore, China, India, Japan, South Korea, Australia, Germany, United Kingdom, France, Italy, Spain, Netherlands, Sweden, Norway, Denmark, Finland, Belgium, Switzerland, and Austria. This broad geographical reach allows the firm to tap into diverse markets and identify promising investment opportunities worldwide.

Synaptic Ventures has a strong track record in the life sciences and healthcare sectors, having raised $50 million in 2024 and 2025 for life science companies. The firm has conducted due diligence on 151 companies since 2020, demonstrating its commitment to thorough evaluation processes. Additionally, Synaptic Ventures has achieved a 96% client satisfaction rate for three consecutive years, reflecting its dedication to delivering value to its portfolio companies. The firm's portfolio includes a biomanufacturing company founded in 2023, showcasing its involvement in innovative healthcare ventures.